Nonalcoholic Steatohepatitis

Hormone identified that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis. A Japanese research team has identified and clarified the mechanism ...

Oct 13, 2016
popularity2 comments 0

Non-alcoholic fatty liver disease (NAFLD) is one cause of a fatty liver, occurring when fat is deposited (steatosis) in the liver not due to excessive alcohol use. It is related to insulin resistance and the metabolic syndrome and may respond to treatments originally developed for other insulin-resistant states (e.g. diabetes mellitus type 2) such as weight loss, metformin and thiazolidinediones. Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD this being regarded as a major cause of cirrhosis of the liver of unknown cause.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Rhythm of breathing affects memory and fear

Northwestern Medicine scientists have discovered for the first time that the rhythm of breathing creates electrical activity in the human brain that enhances emotional judgments and memory recall.

Raising the curtain on cerebral malaria's deadly agents

Using state-of-the-art brain imaging technology, scientists at the National Institutes of Health filmed what happens in the brains of mice that developed cerebral malaria (CM). The results, published in PLOS Pathogens, reveal ...

Rare infant seizure disorder often missed

(HealthDay)—Many infants with a rare form of epilepsy known as infantile spasms aren't promptly diagnosed, and that delay can lead to devastating health consequences, new research indicates.

Want to give a good gift? Think past the 'big reveal'

Gift givers often make critical errors in gift selection during the holiday season, according to a new research article in Current Directions in Psychological Science, a journal of the Association for Psychological Science.